Effect of cilostazol on platelet reactivity among patients with peripheral artery disease on clopidogrel therapy.

Hernandez-Suarez DF, N??ez-Medina H, Scott SA, Lopez-Candales A, Wiley JM, Garcia MJ, Melin K, Nieves-Borrero K, Rodriguez-Ruiz C, Marshall L, Duconge J. Effect of cilostazol on platelet reactivity among patients with peripheral artery disease on clopidogrel therapy. Drug Metab Pers Ther. 2018 03 28; 33(1):49-55.

View in: PubMed

subject areas

Aged
Aryldialkylphosphatase
Blood Platelets
Cross-Sectional Studies
Drug Synergism
Drug Therapy, Combination
Female
Humans
Male
Pilot Projects
Platelet Aggregation Inhibitors
Platelet Function Tests
Tetrazoles
Ticlopidine

authors with profiles

Jorge Duconge
Angel Lopez-Candales
Kyle Melin

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support